Quarterly report pursuant to Section 13 or 15(d)

3. Significant Strategic Drug Development Collaborations (Details Narrative)

v3.7.0.1
3. Significant Strategic Drug Development Collaborations (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Significant Strategic Drug Development Collaborations - Related Parties    
Income from collaborative agreements $ 0 $ 0